EXECUTIVE AGREEMENTExecutive Agreement • March 17th, 2021 • DBV Technologies S.A. • Biological products, (no disgnostic substances) • New Jersey
This EXECUTIVE AGREEMENT (the “Agreement”) between DBV Technologies, Inc. (the “Company”), and Pharis Mohideen (the “Executive”) is effective on July 22, 2019 (the “Effective Date”).
FIRST AMENDMENT TO THE EXECUTIVE AGREEMENT OF DANIEL TASSEExecutive Agreement • March 17th, 2021 • DBV Technologies S.A. • Biological products, (no disgnostic substances)
This FIRST AMENDMENT TO THE EXECUTIVE AGREEMENT OF DANIEL TASSE the “Amendment”) is entered into this 27th day of June 2019 (the “Effective Date”), by and between DANIEL TASSE (the “Executive”) and DBV TECHNOLOGIES S.A. (the “Company”).
EXECUTIVE AGREEMENTExecutive Agreement • March 17th, 2021 • DBV Technologies S.A. • Biological products, (no disgnostic substances) • New Jersey
This EXECUTIVE AGREEMENT (the “Agreement”) between DBV Technologies S.A. (the “Company”), and Daniel Tasse (the “Executive”) is effective as of November 29, 2018 (the “Effective Date”).
